Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology.
Authors:
- B T ColvinBCB T Colvin
- S J MachinSMS J Machin
- T W BarrowcliffeTBT W Barrowcliffe
- M GreavesMGM Greaves
- C A LudlamCLC A Ludlam
- I J MackieIMI J Mackie
- F E PrestonFPF E Preston
- P E RosePRP E Rose
- I D WalkerIWI D Walker
- A H WatersAWA H Waters
Open Access
- 1 December 1993
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 46 (12) , 1069-1070
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society.1992
- Guidance on guidelines.BMJ, 1992
- Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolismThe Lancet, 1992
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1990
- Optimal Therapeutic Range for Oral AnticoagulantsChest, 1989
- Therapeutic Quality Control Leading to Further Clinical Assessment of Oral AnticoagulationActa Haematologica, 1986